M. Efdé

681 total citations
17 papers, 494 citations indexed

About

M. Efdé is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, M. Efdé has authored 17 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 5 papers in Immunology and 4 papers in Nephrology. Recurrent topics in M. Efdé's work include Spondyloarthritis Studies and Treatments (10 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). M. Efdé is often cited by papers focused on Spondyloarthritis Studies and Treatments (10 papers), Rheumatoid Arthritis Research and Therapies (10 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). M. Efdé collaborates with scholars based in Netherlands, United States and Romania. M. Efdé's co-authors include Suzanne Arends, Hendrika Bootsma, Anneke Spoorenberg, E. van der Veer, Tim Jansen, Elisabeth Brouwer, F. Wink, F. Maas, M. Janssen and Viola Klück and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

M. Efdé

16 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Efdé Netherlands 9 265 194 189 88 81 17 494
Gayatri Mittal India 8 191 0.7× 50 0.3× 80 0.4× 87 1.0× 11 0.1× 12 341
Alessandro Lo Nigro Italy 8 246 0.9× 51 0.3× 126 0.7× 73 0.8× 5 0.1× 11 333
Anwar Al‐Awadhi Kuwait 11 68 0.3× 72 0.4× 62 0.3× 115 1.3× 17 0.2× 21 357
Hamdy Abo-Zenah Egypt 10 131 0.5× 38 0.2× 105 0.6× 28 0.3× 70 0.9× 15 347
Hugh Little Canada 7 240 0.9× 52 0.3× 72 0.4× 71 0.8× 22 0.3× 10 346
Pui‐Ying Leong Taiwan 11 151 0.6× 56 0.3× 103 0.5× 24 0.3× 14 0.2× 37 305
Stephanie J. Morris United States 7 229 0.9× 47 0.2× 38 0.2× 34 0.4× 9 0.1× 12 378
Antonella Simpatico Italy 10 117 0.4× 86 0.4× 55 0.3× 27 0.3× 21 0.3× 13 320
B E Bourke United Kingdom 10 112 0.4× 84 0.4× 105 0.6× 35 0.4× 19 0.2× 19 362
H. Franck Germany 10 197 0.7× 63 0.3× 53 0.3× 28 0.3× 8 0.1× 29 392

Countries citing papers authored by M. Efdé

Since Specialization
Citations

This map shows the geographic impact of M. Efdé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Efdé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Efdé more than expected).

Fields of papers citing papers by M. Efdé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Efdé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Efdé. The network helps show where M. Efdé may publish in the future.

Co-authorship network of co-authors of M. Efdé

This figure shows the co-authorship network connecting the top 25 collaborators of M. Efdé. A scholar is included among the top collaborators of M. Efdé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Efdé. M. Efdé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Janssen, M., et al.. (2024). Diagnostic Accuracy of Raman Spectroscopy Integrated With Polarized Light Microscopy for Calcium Pyrophosphate–Associated Arthritis. Arthritis Care & Research. 76(9). 1333–1341. 3 indexed citations
2.
Efdé, M., et al.. (2023). Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone. SHILAP Revista de lepidopterología. 97–105. 2 indexed citations
3.
Efdé, M., et al.. (2023). Test characteristics of Raman spectroscopy integrated with polarized light microscopy for the diagnosis of acute gouty arthritis. Joint Bone Spine. 90(6). 105611–105611. 5 indexed citations
4.
Boonen, Annelies, Casper Webers, Peter M. ten Klooster, et al.. (2021). Treat-to-target in axial spondyloarthritis: an observational study in daily practice. Lara D. Veeken. 61(4). 1396–1407. 8 indexed citations
5.
Klück, Viola, Tim Jansen, M. Janssen, et al.. (2020). Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. The Lancet Rheumatology. 2(5). e270–e280. 197 indexed citations
6.
Jansen, Tim, Viola Klück, M. Janssen, et al.. (2019). P160 The first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout. Annals of the Rheumatic Diseases. 78. A70–A71. 15 indexed citations
7.
Arends, Suzanne, Liesbeth Brouwer, M. Efdé, et al.. (2017). Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice.. PubMed. 35(1). 61–68. 25 indexed citations
8.
Lamers-Karnebeek, F., Jolanda J. Luime, Steven Teerenstra, et al.. (2017). Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors. Lara D. Veeken. 56(9). 1560–1565. 15 indexed citations
9.
Maas, F., Suzanne Arends, Elisabeth Brouwer, et al.. (2016). SAT0379 Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment with Tnf Inhibitors: Results from The Glas Cohort. Annals of the Rheumatic Diseases. 75. 805–805. 2 indexed citations
10.
Maas, F., Suzanne Arends, Elisabeth Brouwer, et al.. (2016). Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors. Arthritis Care & Research. 69(7). 1011–1019. 71 indexed citations
11.
Maas, F., Suzanne Arends, E. van der Veer, et al.. (2015). Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome. The Journal of Rheumatology. 43(2). 383–387. 66 indexed citations
12.
Maas, F., Anneke Spoorenberg, Elisabeth Brouwer, et al.. (2015). Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study. PLoS ONE. 10(4). e0122693–e0122693. 45 indexed citations
13.
Arends, Suzanne, Anneke Spoorenberg, M. Efdé, et al.. (2014). Higher Bone Turnover Is Related to Spinal Radiographic Damage and Low Bone Mineral Density in Ankylosing Spondylitis Patients with Active Disease: A Cross-Sectional Analysis. PLoS ONE. 9(6). e99685–e99685. 22 indexed citations
14.
Maas, F., Anneke Spoorenberg, E. van der Veer, et al.. (2014). THU0077 Prevalence of Obesity and the Relation to Disease Activity, Physical Function, and Quality of Life in Patients with Axial Spondyloarthritis. Annals of the Rheumatic Diseases. 73. 203–203.
15.
Arends, Suzanne, E. van der Veer, M. Efdé, et al.. (2013). FRI0422 Successful dose reduction of tnf-alpha blocking agents in ankylosing spondylitis patients with stable low disease activity. Annals of the Rheumatic Diseases. 72. A517–A517. 1 indexed citations
16.
Maas, F., Anneke Spoorenberg, E. van der Veer, et al.. (2013). Prevalence Of Overweight and Obesity and The Relation To Disease Activity, Physical Function and Quality Of Life In Patients With Axial Spondyloarthritis. Data Archiving and Networked Services (DANS). 65. 1 indexed citations
17.
Efdé, M., et al.. (2005). Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.. PubMed. 63(3). 112–4. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gayatri Mittal Breakdown of academic impact, for papers by Alessandro Lo Nigro Breakdown of academic impact, for papers by Anwar Al‐Awadhi Breakdown of academic impact, for papers by Hamdy Abo-Zenah Breakdown of academic impact, for papers by Hugh Little Breakdown of academic impact, for papers by Pui‐Ying Leong Breakdown of academic impact, for papers by Stephanie J. Morris Breakdown of academic impact, for papers by Antonella Simpatico Breakdown of academic impact, for papers by B E Bourke Breakdown of academic impact, for papers by H. Franck
Rankless by CCL
2026